Drug reaction with eosinophilia and systemic symptoms: Is cutaneous phenotype a prognostic marker for outcome? A review of clinicopathological features of 27 cases

British Journal of Dermatology

Volumn 168, Issue 2, 2013, Pages 391-401

  Walsh, Sarah ^a   Diaz Cano, S ^a   Higgins, E ^a   Morris Jones, R ^a   Bashir, S ^a   Bernal, W ^a   Creamer, D ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; CARBAMAZEPINE; ISONIAZID; MINOCYCLINE; PHENYTOIN; PIPERACILLIN PLUS TAZOBACTAM; SALAZOSULFAPYRIDINE; TRIMETHOPRIM;

ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; DRESS SYNDROME; ERYTHEMA; ERYTHRODERMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KERATINOCYTE; LIVER TRANSPLANTATION; MALE; OUTCOME ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL; RASH; SCHOOL CHILD; SKIN BIOPSY; SKIN DISEASE;

ADULT; AGED; BIOPSY; CHILD; CHILD, PRESCHOOL; DERMATITIS, EXFOLIATIVE; DRUG ERUPTIONS; EOSINOPHILIA; ERYTHEMA; EXANTHEMA; FEMALE; FEVER; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; PROGNOSIS; PROSPECTIVE STUDIES; SKIN; YOUNG ADULT;

EID: 84873143254     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12081     Document Type: Article

References (20)

1. Bocquet H, Bagot M, Roujeau JC,. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms: DRESS). Semin Cutan Med Surg 1996; 15: 250-7.
2. Roujeau JC, Stern RS,. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994; 331: 1272-85.
3. Hunter EB, Johnston PE, Tanner G, et al. Bromfenac (Duract)-associated hepatic failure requiring liver transplantation. Am J Gastroenterol 1999; 94: 2299-301.
4. Blazka ME, Elwell MR, Holladay SD, et al. Histopathology of acetaminophen-induced liver changes: role of interleukin 1 alpha and tumor necrosis factor alpha. Toxicol Pathol 1996; 24: 181-9.
5. Eshki M, Allanore L, Musette P, et al. Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure. Arch Dermatol 2009; 145: 67-72.
6. Chen Y-C, Chiu H-C, Chu C-Y,. Drug reaction with eosinophilia and systemic symptoms: a retrospective study of 60 cases. Arch Dermatol 2010; 146: 1373-9.
7. Bronnimann M, Yawalkar N,. Histopathology of drug-induced exanthems: is there a role in diagnosis of drug allergy? Curr Opin Allergy Clin Immunol 2005; 5: 317-21.
8. Bastuji-Garin S, Fouchard N, Bertocchi M, et al. SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J Invest Dermatol 2000; 115: 149-53.
9. Sekula P, Liss Y, Davidovici B, et al. Evaluation of SCORTEN on a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis included in the RegiSCAR study. J Burn Care Res 2011; 32: 237-45.
10. Quinn AM, Brown K, Bonish BK, et al. Uncovering histologic criteria with prognostic significance in toxic epidermal necrolysis. Arch Dermatol 2005; 141: 683-7.
11. Cacoub P, Musette P, Descamps V, et al. The DRESS syndrome: a literature review. Am J Med 2011; 124: 588-97.
12. Natkunarajah J, Goolamali S, Craythorne E, et al. Ten cases of drug reaction with eosinophilia and systemic symptoms (DRESS) treated with pulsed intravenous methylprednisolone. Eur J Dermatol 2011; 21: 385-91.
13. Kardaun SH, Sidoroff A, Valeyrie-Allanore L, et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol 2007; 156: 609-11.
14. Do-Pham G, Charachon A, Duong TA, et al. Drug reaction with eosinophilia and systemic symptoms and severe involvement of digestive tract: description of two cases. Br J Dermatol 2011; 165: 207-9.
15. Chiou CC, Yang LC, Hung SI, et al. Clinicopathological features and prognosis of drug rash with eosinophilia and systemic symptoms: a study of 30 cases in Taiwan. J Eur Acad Dermatol Venereol 2008; 22: 1044-9.
16. Holt MP, Ju C,. Mechanisms of drug-induced liver injury. AAPS J 2006; 8: E48-54.
17. Parker GA, Picut CA,. Liver immunobiology. Toxicol Pathol 2005; 33: 52-62.
18. Pichler WJ, Yawalkar N, Britschgi M, et al. Cellular and molecular pathophysiology of cutaneous drug reactions. Am J Clin Dermatol 2002; 3: 229-38.
19. Posadas SJ, Padial A, Torres MJ, et al. Delayed reactions to drugs show levels of perforin, granzyme B, and Fas-L to be related to disease severity. J Allergy Clin Immunol 2002; 109: 155-61.
20. Tohyama M, Hashimoto K, Yasukawa M, et al. Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome. Br J Dermatol 2007; 157: 934-40.